Lei Diao

Key Laboratory Of Cancer Prevention And Therapy
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Correction: Neoadjuvant and/or adjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced resectable penile squamous cell carcinoma.

Correction: Neoadjuvant and/or adjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced resectable penile squamous cell carcinoma.

Journal: Frontiers in immunology

Published: April 22, 2026

Neoadjuvant and/or adjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced resectable penile squamous cell carcinoma.

Neoadjuvant and/or adjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced resectable penile squamous cell carcinoma.

Journal: Frontiers in immunology

Published: October 24, 2025

Phase 1 Study of Luvometinib Use in Pediatric Patients with Neurofibromatosis Type 1-Related Unresectable Plexiform Neurofibromas.

Phase 1 Study of Luvometinib Use in Pediatric Patients with Neurofibromatosis Type 1-Related Unresectable Plexiform Neurofibromas.

Journal: Targeted oncology

Published: April 25, 2025

Assessing pentafecta achievement and survival of retroperitoneal robotic partial nephrectomy for anterior tumors: An update on the outcomes of a long-term follow-up.

Assessing pentafecta achievement and survival of retroperitoneal robotic partial nephrectomy for anterior tumors: An update on the outcomes of a long-term follow-up.

Journal: Urologic oncology

Published: March 14, 2025

Fruquintinib Plus Sintilimab in Patients with Treatment-Naive and Previously Treated Advanced Renal Cell Carcinoma: Results from a Phase Ib/II Clinical Trial.

Fruquintinib Plus Sintilimab in Patients with Treatment-Naive and Previously Treated Advanced Renal Cell Carcinoma: Results from a Phase Ib/II Clinical Trial.

Journal: Targeted oncology

Published: December 03, 2024

Ultrathin Mo2S3 Nanowire Network for High-Sensitivity Breathable Piezoresistive Electronic Skins.

Ultrathin Mo2S3 Nanowire Network for High-Sensitivity Breathable Piezoresistive Electronic Skins.

Journal: ACS nano

Published: February 24, 2023

Use of PARP inhibitors in prostate cancer: from specific to broader application.

Use of PARP inhibitors in prostate cancer: from specific to broader application.

Journal: Frontiers in endocrinology

Published: February 12, 2023

Comparison of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma with rhabdoid and sarcomatoid differentiations.

Comparison of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma with rhabdoid and sarcomatoid differentiations.

Journal: Cancer medicine

Published: September 01, 2022

Low differentiated microvascular density and low expression of platelet-derived growth factor-BB (PDGF-BB) predict distant metastasis and poor prognosis in clear cell renal cell carcinoma.

Low differentiated microvascular density and low expression of platelet-derived growth factor-BB (PDGF-BB) predict distant metastasis and poor prognosis in clear cell renal cell carcinoma.

Journal: BJU international

Published: July 25, 2013

Critical role of TRPC6 channels in the development of human renal cell carcinoma.

Critical role of TRPC6 channels in the development of human renal cell carcinoma.

Journal: Molecular biology reports

Published: August 04, 2012

A substrate pharmacophore for the human organic cation/carnitine transporter identifies compounds associated with rhabdomyolysis.

A substrate pharmacophore for the human organic cation/carnitine transporter identifies compounds associated with rhabdomyolysis.

Journal: Molecular pharmaceutics

Published: February 21, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026